Table of Contents

1 Study Coverage

• 1.1 Biotechnological Drugs Revenue in Biotechnological Drugs Business (2017-2022) & (US$ Million) Introduction
• 1.2 Global Biotechnological Drugs Outlook 2017 VS 2022 VS 2028
  • 1.2.1 Global Biotechnological Drugs Market Size for the Year 2017-2028
  • 1.2.2 Global Biotechnological Drugs Market Size for the Year 2017-2028
• 1.3 Biotechnological Drugs Market Size, United States VS Global, 2017 VS 2022 VS 2028
  • 1.3.1 The Market Share of United States Biotechnological Drugs in Global, 2017 VS 2022 VS 2028
  • 1.3.2 The Growth Rate of Biotechnological Drugs Market Size, United States VS Global, 2017 VS 2022 VS 2028
• 1.4 Biotechnological Drugs Market Dynamics
  • 1.4.1 Biotechnological Drugs Industry Trends
  • 1.4.2 Biotechnological Drugs Market Drivers
  • 1.4.3 Biotechnological Drugs Market Challenges
  • 1.4.4 Biotechnological Drugs Market Restraints
• 1.5 Study Objectives
• 1.6 Years Considered

2 Biotechnological Drugs by Type

• 2.1 Biotechnological Drugs Market Segment by Type
  • 2.1.1 Genetically Engineered Drugs
  • 2.1.2 Therapeutic Monoclonal Antibody Drugs
  • 2.1.3 Gene Therapy and Nucleic Acid Drugs
  • 2.1.4 Genetically Engineered Vaccines
  • 2.1.5 Other
• 2.2 Global Biotechnological Drugs Market Size by Type (2017, 2022 & 2028)
• 2.3 Global Biotechnological Drugs Market Size by Type (2017-2028)
• 2.4 United States Biotechnological Drugs Market Size by Type (2017, 2022 & 2028)
• 2.5 United States Biotechnological Drugs Market Size by Type (2017-2028)

3 Biotechnological Drugs by Application

• 3.1 Biotechnological Drugs Market Segment by Application
  • 3.1.1 Tumor
  • 3.1.2 Autoimmune Disease
  • 3.1.3 Other
• 3.2 Global Biotechnological Drugs Market Size by Application (2017, 2022 & 2028)
• 3.3 Global Biotechnological Drugs Market Size by Application (2017-2028)
• 3.4 United States Biotechnological Drugs Market Size by Application (2017, 2022 & 2028)
• 3.5 United States Biotechnological Drugs Market Size by Application (2017-2028)

4 Global Biotechnological Drugs Competitor Landscape by Company

• 4.1 Global Biotechnological Drugs Market Size by Company
  • 4.1.1 Top Global Biotechnological Drugs Companies Ranked by Revenue (2021)
  • 4.1.2 Global Biotechnological Drugs Revenue by Player (2017-2022)
• 4.2 Global Biotechnological Drugs Concentration Ratio (CR)
  • 4.2.1 Biotechnological Drugs Market Concentration Ratio (CR) (2017-2022)
  • 4.2.2 Global Top 5 and Top 10 Largest Companies of Biotechnological Drugs in 2021
  • 4.2.3 Global Biotechnological Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
• 4.3 Global Biotechnological Drugs Headquarters, Revenue in Biotechnological Drugs Business (2017-2022) & (US$ Million) Type
  • 4.3.1 Global Biotechnological Drugs Headquarters and Area Served
  • 4.3.2 Global Biotechnological Drugs Companies Revenue in Biotechnological Drugs Business (2017-2022) & (US$ Million) Type
  • 4.3.3 Date of International Companies Enter into Biotechnological Drugs Market
• 4.4 Companies Mergers & Acquisitions, Expansion Plans
• 4.5 United States Biotechnological Drugs Market Size by Company
  • 4.5.1 Top Biotechnological Drugs Players in United States, Ranked by Revenue (2021)
  • 4.5.2 United States Biotechnological Drugs Revenue by Players (2020, 2021 & 2022)

5 Global Biotechnological Drugs Market Size by Region

• 5.1 Global Biotechnological Drugs Market Size by Region: 2017 VS 2022 VS 2028
• 5.2 Global Biotechnological Drugs Market Size by Region (2017-2028)
  • 5.2.1 Global Biotechnological Drugs Market Size by Region: 2017-2022
  • 5.2.2 Global Biotechnological Drugs Market Size by Region (2023-2028)

6 Segment in Region Level & Country Level

• 6.1 North America
  • 6.1.1 North America Biotechnological Drugs Market Size YoY Growth 2017-2028
  • 6.1.2 North America Biotechnological Drugs Market Facts & Figures by Country (2017, 2022 & 2028)
  • 6.1.3 United States
  • 6.1.4 Canada
• 6.2 Asia-Pacific
  • 6.2.1 Asia-Pacific Biotechnological Drugs Market Size YoY Growth 2017-2028
  • 6.2.2 Asia-Pacific Biotechnological Drugs Market Facts & Figures by Region (2017, 2022 & 2028)
  • 6.2.3 China
  • 6.2.4 Japan
  • 6.2.5 South Korea
  • 6.2.6 India
  • 6.2.7 Australia
  • 6.2.8 China Taiwan
  • 6.2.9 Indonesia
  • 6.2.10 Thailand
  • 6.2.11 Malaysia
• 6.3 Europe
  • 6.3.1 Europe Biotechnological Drugs Market Size YoY Growth 2017-2028
  • 6.3.2 Europe Biotechnological Drugs Market Facts & Figures by Country (2017, 2022 & 2028)
  • 6.3.3 Germany
  • 6.3.4 France
  • 6.3.5 U.K.
  • 6.3.6 Italy
  • 6.3.7 Russia
• 6.4 Latin America
  • 6.4.1 Latin America Biotechnological Drugs Market Size YoY Growth 2017-2028
  • 6.4.2 Latin America Biotechnological Drugs Market Facts & Figures by Country (2017, 2022 & 2028)
  • 6.4.3 Mexico
  • 6.4.4 Brazil
  • 6.4.5 Argentina
• 6.5 Middle East and Africa
  • 6.5.1 Middle East and Africa Biotechnological Drugs Market Size YoY Growth 2017-2028
  • 6.5.2 Middle East and Africa Biotechnological Drugs Market Facts & Figures by Country (2017, 2022 & 2028)
  • 6.5.3 Turkey
  • 6.5.4 Saudi Arabia
  • 6.5.5 UAE

7 Company Profiles

• 7.1 3SBIO
  • 7.1.1 3SBIO Company Details
  • 7.1.2 3SBIO Business Overview
  • 7.1.3 3SBIO Biotechnological Drugs Introduction
  • 7.1.4 3SBIO Revenue in Biotechnological Drugs Business (2017-2022)
  • 7.1.5 3SBIO Recent Development
• 7.2 Anhui Anke Biotechnology
  • 7.2.1 Anhui Anke Biotechnology Company Details
  • 7.2.2 Anhui Anke Biotechnology Business Overview
  • 7.2.3 Anhui Anke Biotechnology Biotechnological Drugs Introduction
  • 7.2.4 Anhui Anke Biotechnology Revenue in Biotechnological Drugs Business (2017-2022)
  • 7.2.5 Anhui Anke Biotechnology Recent Development
• 7.3 Beijing SL Pharmaceutical
  • 7.3.1 Beijing SL Pharmaceutical Company Details
  • 7.3.2 Beijing SL Pharmaceutical Business Overview
  • 7.3.3 Beijing SL Pharmaceutical Biotechnological Drugs Introduction
  • 7.3.4 Beijing SL Pharmaceutical Revenue in Biotechnological Drugs Business (2017-2022)
  • 7.3.5 Beijing SL Pharmaceutical Recent Development
• 7.4 Biotech Pharmaceutical
  • 7.4.1 Biotech Pharmaceutical Company Details
  • 7.4.2 Biotech Pharmaceutical Business Overview
  • 7.4.3 Biotech Pharmaceutical Biotechnological Drugs Introduction
  • 7.4.4 Biotech Pharmaceutical Revenue in Biotechnological Drugs Business (2017-2022)
  • 7.4.5 Biotech Pharmaceutical Recent Development
• 7.5 Cadila Healthcare
  • 7.5.1 Cadila Healthcare Company Details
  • 7.5.2 Cadila Healthcare Business Overview
  • 7.5.3 Cadila Healthcare Biotechnological Drugs Introduction
  • 7.5.4 Cadila Healthcare Revenue in Biotechnological Drugs Business (2017-2022)
  • 7.5.5 Cadila Healthcare Recent Development
• 7.6 Celgen Biopharma
  • 7.6.1 Celgen Biopharma Company Details
  • 7.6.2 Celgen Biopharma Business Overview
  • 7.6.3 Celgen Biopharma Biotechnological Drugs Introduction
  • 7.6.4 Celgen Biopharma Revenue in Biotechnological Drugs Business (2017-2022)
  • 7.6.5 Celgen Biopharma Recent Development
• 7.7 Celltrion
  • 7.7.1 Celltrion Company Details
  • 7.7.2 Celltrion Business Overview
  • 7.7.3 Celltrion Biotechnological Drugs Introduction
  • 7.7.4 Celltrion Revenue in Biotechnological Drugs Business (2017-2022)
  • 7.7.5 Celltrion Recent Development
• 7.8 Dr Reddy’s
  • 7.8.1 Dr Reddy’s Company Details
  • 7.8.2 Dr Reddy’s Business Overview
  • 7.8.3 Dr Reddy’s Biotechnological Drugs Introduction
  • 7.8.4 Dr Reddy’s Revenue in Biotechnological Drugs Business (2017-2022)
  • 7.8.5 Dr Reddy’s Recent Development
• 7.9 GeneScience Pharmaceuticals
  • 7.9.1 GeneScience Pharmaceuticals Company Details
  • 7.9.2 GeneScience Pharmaceuticals Business Overview
  • 7.9.3 GeneScience Pharmaceuticals Biotechnological Drugs Introduction
  • 7.9.4 GeneScience Pharmaceuticals Revenue in Biotechnological Drugs Business (2017-2022)
  • 7.9.5 GeneScience Pharmaceuticals Recent Development
• 7.10 Hisun Pharma
  • 7.10.1 Hisun Pharma Company Details
  • 7.10.2 Hisun Pharma Business Overview
  • 7.10.3 Hisun Pharma Biotechnological Drugs Introduction
  • 7.10.4 Hisun Pharma Revenue in Biotechnological Drugs Business (2017-2022)
  • 7.10.5 Hisun Pharma Recent Development
• 7.11 Jiangsu Sihuan Bioengineering
  • 7.11.1 Jiangsu Sihuan Bioengineering Company Details
  • 7.11.2 Jiangsu Sihuan Bioengineering Business Overview
  • 7.11.3 Jiangsu Sihuan Bioengineering Biotechnological Drugs Introduction
  • 7.11.4 Jiangsu Sihuan Bioengineering Revenue in Biotechnological Drugs Business (2017-2022)
  • 7.11.5 Jiangsu Sihuan Bioengineering Recent Development
• 7.12 Novartis (Sandoz)
  • 7.12.1 Novartis (Sandoz) Company Details
  • 7.12.2 Novartis (Sandoz) Business Overview
  • 7.12.3 Novartis (Sandoz) Biotechnological Drugs Introduction
  • 7.12.4 Novartis (Sandoz) Revenue in Biotechnological Drugs Business (2017-2022)
  • 7.12.5 Novartis (Sandoz) Recent Development
• 7.13 Pfizer (Hospira)
  • 7.13.1 Pfizer (Hospira) Company Details
  • 7.13.2 Pfizer (Hospira) Business Overview
  • 7.13.3 Pfizer (Hospira) Biotechnological Drugs Introduction
  • 7.13.4 Pfizer (Hospira) Revenue in Biotechnological Drugs Business (2017-2022)
  • 7.13.5 Pfizer (Hospira) Recent Development
• 7.14 Shanghai Lansheng Guojian Pharmaceutical
  • 7.14.1 Shanghai Lansheng Guojian Pharmaceutical Company Details
  • 7.14.2 Shanghai Lansheng Guojian Pharmaceutical Business Overview
  • 7.14.3 Shanghai Lansheng Guojian Pharmaceutical Biotechnological Drugs Introduction
  • 7.14.4 Shanghai Lansheng Guojian Pharmaceutical Revenue in Biotechnological Drugs Business (2017-2022)
  • 7.14.5 Shanghai Lansheng Guojian Pharmaceutical Recent Development
• 7.15 Shenzhen Neptunus Interlong Bio-Technique
  • 7.15.1 Shenzhen Neptunus Interlong Bio-Technique Company Details
  • 7.15.2 Shenzhen Neptunus Interlong Bio-Technique Business Overview
  • 7.15.3 Shenzhen Neptunus Interlong Bio-Technique Biotechnological Drugs Introduction
  • 7.15.4 Shenzhen Neptunus Interlong Bio-Technique Revenue in Biotechnological Drugs Business (2017-2022)
  • 7.15.5 Shenzhen Neptunus Interlong Bio-Technique Recent Development
• 7.16 Tonghua Dongbao Pharmaceutical
  • 7.16.1 Tonghua Dongbao Pharmaceutical Company Details
  • 7.16.2 Tonghua Dongbao Pharmaceutical Business Overview
  • 7.16.3 Tonghua Dongbao Pharmaceutical Biotechnological Drugs Introduction
  • 7.16.4 Tonghua Dongbao Pharmaceutical Revenue in Biotechnological Drugs Business (2017-2022)
  • 7.16.5 Tonghua Dongbao Pharmaceutical Recent Development
• 7.17 Torrent Pharmaceuticals
  • 7.17.1 Torrent Pharmaceuticals Company Details
  • 7.17.2 Torrent Pharmaceuticals Business Overview
  • 7.17.3 Torrent Pharmaceuticals Biotechnological Drugs Introduction
  • 7.17.4 Torrent Pharmaceuticals Revenue in Biotechnological Drugs Business (2017-2022)
  • 7.17.5 Torrent Pharmaceuticals Recent Development

8 Research Findings and Conclusion

9 Appendix

• 9.1 Research Methodology
  • 9.1.1 Methodology/Research Approach
  • 9.1.2 Data Source
• 9.2 Author Details

Summary:

Market Analysis and Insights: Global and United States Biotechnological Drugs Market
This report focuses on global and United States Biotechnological Drugs market, also covers the segmentation data of other regions in regional level and county level.
Due to the COVID-19 pandemic, the global Biotechnological Drugs market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the review period. Fully considering the economic change by this health crisis, by Type, Genetically Engineered Drugs accounting for % of the Biotechnological Drugs global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period. While by Application, Tumor was the leading segment, accounting for over percent market share in 2021, and altered to an % CAGR throughout this forecast period.
In United States the Biotechnological Drugs market size is expected to grow from US$ million in 2021 to US$ million by 2028, at a CAGR of % during the forecast period.
Global Biotechnological Drugs Scope and Market Size
Biotechnological Drugs market is segmented by region (country), players, by Type and by Application. Players, stakeholders, and other participants in the global Biotechnological Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application for the period 2017-2028.
For United States market, this report focuses on the Biotechnological Drugs market size by players, by Type and by Application, for the period 2017-2028. The key players include the global and local players, which play important roles in United States.
Segment by Type, the Biotechnological Drugs market is segmented into
Genetically Engineered Drugs
Therapeutic Monoclonal Antibody Drugs
Gene Therapy and Nucleic Acid Drugs
Genetically Engineered Vaccines
Other
Segment by Application, the Biotechnological Drugs market is segmented into
Tumor
Autoimmune Disease
Other
Regional and Country-level Analysis
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Competitive Landscape and Biotechnological Drugs Market Share Analysis
Biotechnological Drugs market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2017-2022. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2017-2022. Details included are company description, major business, company total revenue and the sales, revenue generated in Biotechnological Drugs business, the date to enter into the Biotechnological Drugs market, Revenue in Biotechnological Drugs Business (2017-2022) & (US$ Million) introduction, recent developments, etc.
The major vendors covered:
3SBIO
Anhui Anke Biotechnology
Beijing SL Pharmaceutical
Biotech Pharmaceutical
Cadila Healthcare
Celgen Biopharma
Celltrion
Dr Reddy’s
GeneScience Pharmaceuticals
Hisun Pharma
Jiangsu Sihuan Bioengineering
Novartis (Sandoz)
Pfizer (Hospira)
Shanghai Lansheng Guojian Pharmaceutical
Shenzhen Neptunus Interlong Bio-Technique
Tonghua Dongbao Pharmaceutical
Torrent Pharmaceuticals